Chris comes to Clear Oncology after spending 28 years in the oncology pharmaceutical industry. During this time, he spent the first 21 years working for Johnson & Johnson’s oncology company, Ortho Biotech, which eventually became Janssen Oncology. During his tenure, he held numerous positions giving him expertise in Sales, Sales Training and Development, Sales Management, Contracting, Market Access, Reimbursement, and Key Account Management. While holding various positions, Chris found himself very intrigued by the dynamics of the business side of oncology. He quickly realized the challenges the community oncologists faced with cuts in drug reimbursement and market consolidation. During this time, he gave talks on the Affordable Care Act (Healthcare Reform) and how it would impact the oncology community. Topics such as the Oncology Care Model, Medicare Part D, Medicaid Expansion, and the Healthcare Exchanges were in high demand.
In 2017, Chris was recruited away from Johnson & Johnson to launch AstraZeneca’s first Hematology Franchise. Within nine months he was quickly promoted to the Commercial Business Director role, heading up sales for the western half of the United States. Over the next 6 years, he built strong relationships with key customers, while his team led the Hematology portfolio to blockbuster status. In Chris’s role as the Chief Executive Officer, he will focus on instilling a strong community oncology practice strategy that benefits the patients and the practice. His goal is to make mental health screening for cancer patients standard of care and believes a patient with a stable mindset can be more adherent to the treatment plan leading to better outcomes. Chris also believes Clear Oncology’s mental health data will be the first of its kind and will reveal trends and insights to help shape the way patients are treated.

Bill has enjoyed a diverse 30+ year career that spans education, consulting, customer support, manufacturing, distribution, supply chain management, CRM software, medical devices, and entrepreneurship. He began his career at the State Correctional Institution at Hunlock Creek, where he taught business courses and served as the department representative on the parole board. He then spent nearly five years as a key member of a distribution and inventory management software firm, helping to grow the Los Angeles office’s consultancy and training groups before moving into a sales role for the North Central California District. Additionally, Bill worked as an independent consultant, improving processes and software for distribution and retail outlets.

Bill expanded his experience in the software industry with 9+ years at QAD, Inc., where he specialized in multi-site, multi-currency global manufacturing implementations with a focus on finance. He established training and certification processes for consulting entities and led large system integrations for major clients such as Alcatel-Framatome, Schlumberger, General Electric, and Philips Electronics. His international work took him to facilities in Singapore, Hungary, France, England, The Netherlands, Mexico, Canada, and Belgium.

He then spent nearly two years at Siebel Systems, Inc. in the automotive division, managing sales for Nissan, Suzuki, and Mitsubishi and overseeing partner implementations with IBM, Deloitte, and Grant Thornton. Bill’s entrepreneurial journey includes helping to lead iVu Imaging, Inc. as Regional Director and Controller, achieving FDA approval for the first Fully Automated Breast Tomography System. He also co-founded HEALO 5 Corporation, launching a Patient Education Program aimed at preventing opioid addiction. Using analytics and constant updates, the program has been instrumental in helping individuals avoid addiction early in the opioid use cycle.